 | Elizabeth Yeu, M.D. and K. Peony Yu, M.D. Appointed to STAAR Surgical Board of Directors - Business Wire businesswire.com - January 26 at 2:26 PM |
 | FibroGen (NASDAQ:FGEN) Stock Price Up 6.6% americanbankingnews.com - January 22 at 7:39 PM |
 | FibroGen (NASDAQ:FGEN) Stock Price Up 9.4% americanbankingnews.com - January 14 at 8:26 PM |
 | FGEN Crosses Above Key Moving Average Level nasdaq.com - January 14 at 6:32 PM |
 | FibroGen (NASDAQ:FGEN) Stock Crosses Below Fifty Day Moving Average of $40.40 americanbankingnews.com - January 12 at 6:22 AM |
 | FibroGen: Roxadustat's U.S. Approval, 2020 China Sales, And Outsized Growth - Seeking Alpha seekingalpha.com - December 24 at 7:10 PM |
 | Who Has Been Buying FibroGen, Inc. (NASDAQ:FGEN) Shares? - Yahoo Finance finance.yahoo.com - December 23 at 12:16 PM |
 | Who Has Been Buying FibroGen, Inc. (NASDAQ:FGEN) Shares? finance.yahoo.com - December 23 at 12:16 PM |
 | Dosing underway in FibroGen's late-stage pamrevlumab study in chronic lung disease - Seeking Alpha seekingalpha.com - December 22 at 5:46 PM |
 | Why FibroGen Got Mashed on Monday - Motley Fool fool.com - December 22 at 12:45 PM |
|
 | FibroGen Advances Phase 3 Clinical Development of Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis with Initiation of ZEPHYRUS-2 - GlobeNewswire globenewswire.com - December 22 at 7:45 AM |
 | FibroGen Advances Phase 3 Clinical Development of Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis with Initiation of ZEPHYRUS-2 finance.yahoo.com - December 22 at 7:45 AM |
 | Why FibroGen Got Mashed on Monday finance.yahoo.com - December 21 at 7:54 PM |
 | After nearly $1 billion and 27 years, S.F. biotech now must wait another 90 days for 1st FDA decision - San Francisco Business Times bizjournals.com - December 21 at 2:53 PM |
 | AstraZeneca (AZN) announces update on US regulatory review of roxadustat - StreetInsider.com streetinsider.com - December 21 at 9:53 AM |
 | AstraZeneca Says FDA Extends Review Period Of FibroGen's Anaemia Drug Roxadustat By Three Months - Nasdaq nasdaq.com - December 21 at 9:53 AM |
 | FibroGen’s action date for Roxadustat postponed - Seeking Alpha seekingalpha.com - December 20 at 12:23 AM |
 | After 20 years and founder's sudden death, S.F. biotech wins 1st FDA drug approval - San Francisco Business Times bizjournals.com - December 19 at 9:23 AM |
 | Four years after grabbing shelved drug, Peninsula company wins FDA approval in prostate cancer - San Francisco Business Times bizjournals.com - December 18 at 7:12 PM |
 | FibroGen Provides Regulatory Update on Roxadustat Nasdaq:FGEN - GlobeNewswire globenewswire.com - December 18 at 7:12 PM |
 | FibroGen Provides Regulatory Update on Roxadustat finance.yahoo.com - December 18 at 7:12 PM |
 | First Week of February 2021 Options Trading For FibroGen (FGEN) - Nasdaq nasdaq.com - December 18 at 2:12 PM |
 | Notable Friday Option Activity: FEYE, FGEN, DD nasdaq.com - December 11 at 6:55 PM |
 | FibroGen Announces Retirement of K. Peony Yu, M.D., and Appointment of Mark Eisner, M.D., M.P.H. as Chief Medical Officer - Yahoo Finance finance.yahoo.com - December 3 at 2:21 AM |
 | FibroGen to Present Safety and Efficacy Analyses from Roxadustat Global Phase 3 Program at American Society of Hematology Annual Meeting - GlobeNewswire globenewswire.com - December 2 at 8:47 AM |
 | Two local biotechs harvest top-level execs from Genentech - San Francisco Business Times bizjournals.com - December 1 at 10:46 PM |
 | FibroGen Announces Retirement of K. Peony Yu, M.D., and Appointment of Mark Eisner, M.D., M.P.H. as Chief Medical Officer - GlobeNewswire globenewswire.com - December 1 at 4:55 PM |
 | FibroGen Announces Retirement of K. Peony Yu, M.D., and Appointment of Mark Eisner, M.D., M.P.H. as Chief Medical Officer finance.yahoo.com - December 1 at 4:55 PM |
|
 | FibroGen's (FGEN) Evrenzo Approved in Japan for Another Indication - Nasdaq nasdaq.com - November 30 at 5:09 PM |
 | FibroGen's (FGEN) Evrenzo Approved in Japan for Another Indication finance.yahoo.com - November 30 at 5:09 PM |
 | FibroGen Gains Japanese Approval for Roxadustat; Mizuho Securities Sees 79% Upside - Nasdaq nasdaq.com - November 29 at 9:24 PM |
 | FibroGen Gains Japanese Approval for Roxadustat; Mizuho Securities Sees 79% Upside - Yahoo Finance finance.yahoo.com - November 29 at 4:24 PM |
 | FibroGen Gains Japanese Approval for Roxadustat; Mizuho Securities Sees 79% Upside finance.yahoo.com - November 29 at 4:24 PM |
 | Astellas Pharma and FibroGen's roxadustat Ok'd in Japan for renal anemia - Seeking Alpha seekingalpha.com - November 27 at 5:29 PM |
 | FibroGen Breaks Below 200-Day Moving Average - Notable for FGEN - Nasdaq nasdaq.com - November 20 at 8:38 PM |
 | FibroGen Breaks Below 200-Day Moving Average - Notable for FGEN - Nasdaq nasdaq.com - November 20 at 8:38 PM |
 | FibroGen, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates nasdaq.com - November 8 at 1:51 PM |
 | FibroGen, Inc. (FGEN) CEO Enrique Conterno on Q3 2020 Results - Earnings Call Transcript seekingalpha.com - November 8 at 1:51 PM |
 | FibroGen, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates - Yahoo Finance finance.yahoo.com - November 8 at 8:50 AM |
 | FibroGen, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates finance.yahoo.com - November 8 at 8:50 AM |
 | FibroGen (FGEN) Q3 Earnings Beat Estimates - Yahoo Finance finance.yahoo.com - November 6 at 11:05 PM |
 | FibroGen Inc (FGEN) Q3 2020 Earnings Call Transcript - Motley Fool fool.com - November 6 at 6:04 PM |
 | FibroGen: 3Q Earnings Snapshot - Yahoo Finance finance.yahoo.com - November 6 at 8:02 AM |
 | FibroGen (FGEN) Q3 Earnings Beat Estimates - Nasdaq nasdaq.com - November 6 at 8:02 AM |
 | FibroGen, Inc. to Host Earnings Call - Yahoo Finance finance.yahoo.com - November 5 at 7:55 PM |
 | FibroGen Reports Third Quarter 2020 Financial Results Nasdaq:FGEN - GlobeNewswire globenewswire.com - November 5 at 7:55 PM |
 | FibroGen, Inc. to Host Earnings Call finance.yahoo.com - November 5 at 7:55 PM |
 | FibroGen Reports Third Quarter 2020 Financial Results finance.yahoo.com - November 5 at 7:55 PM |
 | FibroGen (FGEN) Q3 Earnings Beat Estimates finance.yahoo.com - November 5 at 7:55 PM |
 | FibroGen Q3 2020 Earnings Preview - Seeking Alpha seekingalpha.com - November 4 at 1:15 PM |